We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

6 hedge funds and large institutions have $3.04M invested in Eterna Therapeutics in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 6 → 6 (0)

51% less capital invested

Capital invested by funds: $6.18M → $3.04M (-$3.14M)

Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
AIC
1
AWM Investment Company
New York
$1.45M – – –
EAM
2
Eagle Asset Management
Florida
$737K – – –
MHP
3
Manatuck Hill Partners
Connecticut
$300K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$205K – – –
Renaissance Technologies
5
Renaissance Technologies
New York
$130K – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$106K – – –
State of New Jersey Common Pension Fund D
7
State of New Jersey Common Pension Fund D
New Jersey
$32K – – –
BIT
8
BlackRock Institutional Trust
California
$21K – – –
Goldman Sachs
9
Goldman Sachs
New York
$16K – – –
VKH
10
Virtu KCG Holdings
New York
$11K – – –
OC
11
Oppenheimer & Co
New York
$9K – – –
Northern Trust
12
Northern Trust
Illinois
$5K – – –
ADL
13
Asset Dedication LLC
California
$2K – – –
BFA
14
BlackRock Fund Advisors
California
$2K – – –
Citadel Advisors
15
Citadel Advisors
Florida
$2K – – –
UBS Group
16
UBS Group
Switzerland
$2K – – –
IIC
17
Integrated Investment Consultants
Michigan
$1K – – –
TRCT
18
Tower Research Capital (TRC)
New York
$1K – – –
Manulife (Manufacturers Life Insurance)
19
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1 – – –

ERNA Hedge Fund Activity: Q4 2015 in Review

6 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q4 2015, worth a combined $3.04M — down 51% from $6.18M a quarter earlier.

Fund positioning in ERNA was balanced in Q4 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 6 institutional investors held Eterna Therapeutics (ERNA) as of Q4 2015, unchanged from Q3 2015.
  • Funds reported $3.04M of Eterna Therapeutics stock for Q4 2015, down 51% quarter-over-quarter.
  • 0 funds opened new Eterna Therapeutics positions in Q4 2015 and 0 closed out.

Based on aggregated 13F filings for Q4 2015.